肺癌与食管癌切除术患者的经济毒性风险
基于2012至2021年美国全国住院患者样本,分析384,340例因癌症接受肺叶切除、全肺切除或食管切除术的成人。经济毒性风险定义为自付费用超过生存后收入的40%,结果约68.9%无保险者和17.3%有保险者处于风险中,且并发症使无保险者风险增加逾2倍。
要点
- 约68.9%无保险者和17.3%有保险者存在经济毒性风险。
- 无保险患者中并发症与经济毒性风险增加逾2倍相关(aOR 2.21)。
- 有保险者中黑人、西班牙裔和公共保险患者经济毒性风险更高。
核心结论
- 胸外科手术的经济毒性负担与腹部肿瘤外科相当。
- 建议对高风险患者考虑转诊政策和医疗补贴。
研究设计与样本
- 回顾性队列研究,使用2012至2021年美国全国住院患者样本。
- 纳入因癌症接受肺叶切除、全肺切除或食管切除术的成人共384,340例。
主要发现
- 69.5%患者为政府资助保险,27.2%为私人保险,1.0%无保险。
- 无保险患者中黑人和西班牙裔比例更高,择期入院比例更低。
- 无论保险状态,死亡率、并发症、住院时间和费用相当。
- 约68.9%无保险者和17.3%有保险者存在经济毒性风险,且发生率随时间稳定。
- 风险调整后,无保险患者中并发症与经济毒性风险增加逾2倍相关(aOR 2.21;95%CI 1.38-3.55)。
关键数值与推荐
- 经济毒性风险定义为医疗支出(无保险者为总住院费用,有保险者为最高自付费用)超过生存后收入的40%。
- 有保险患者中,黑人、西班牙裔和公共保险患者经济毒性风险更高。
- 有保险患者中,微创手术和大都市医院就诊与经济毒性风险更低相关。
临床怎么用
- 对接受胸外科肿瘤切除术的患者应评估经济毒性风险。
- 对无保险、少数族裔、公共保险等高危患者可考虑转诊政策和医疗补贴。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although financial toxicity, defined as the harmful financial burden experienced by patients undergoing cancer treatment, has been of growing interest, data in thoracic oncology are lacking. This study aimed to examine the risk of financial toxicity among patients undergoing surgical resection of thoracic malignant diseases. METHODS: Adults undergoing lobectomy, pneumonectomy, or esophagectomy for cancer were identified in the 2012 to 2021 National Inpatient Sample. Risk of financial toxicity was defined as health expenditure (total hospitalization costs for the uninsured and maximum out-of-pocket costs for the insured) exceeding 40% of postsubsistence income. Multivariable logistic regressions were used to identify factors associated with financial toxicity risk. RESULTS: Of 384,340 patients, 69.5% had government-funded insurance, 27.2% had private insurance, and 1.0% were uninsured. Compared with patients with insurance, uninsured patients were more commonly Black and Hispanic and less commonly electively admitted. Mortality, complications, length of stay, and costs were comparable regardless of insurance status. Approximately 68.9% of uninsured and 17.3% of insured patients were at risk of financial toxicity, and the incidence of financial toxicity remained stable over time. After risk adjustment, complications were associated with a greater than 2-fold increased risk of financial toxicity among uninsured patients (adjusted odds ratio, 2.21; 95% CI, 1.38-3.55). Among the insured patients, Black, Hispanic, and publicly insured patients demonstrated a greater risk of financial toxicity, while patients undergoing minimally invasive operations and receiving care at metropolitan hospitals exhibited a lower risk of financial toxicity. CONCLUSIONS: Concordant with previous work examining financial toxicity in abdominal oncologic surgery, thoracic surgery demonstrates a comparable burden of financial toxicity. Referral policies and care subsidization may be considered in patients at risk for financial toxicity who are undergoing resections for thoracic malignant diseases.
引用
- Ng AP, Sanaiha Y, Hadaya JE, et al. Risk of Financial Toxicity Among Adults Undergoing Lung and Esophageal Resections for Cancer. Ann Thorac Surg. 2024. PMID: 39515742. doi:10.1016/j.athoracsur.2024.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。